China Oncology ›› 2021, Vol. 31 ›› Issue (7): 567-573.doi: 10.19401/j.cnki.1007-3639.2021.07.002

• Specialists’ Commentary • Previous Articles     Next Articles

Advances in clinical diagnosis and treatment of gastroenteropancreatic neuroendocrine tumor G3

GAO Heli, XU Jin, YU Xianjun   

  1. Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University; Pancreatic Cancer Institute, Fudan University; Shanghai Pancreatic Cancer Institute, Shanghai 200032, China
  • Online:2021-07-30 Published:2021-08-03
  • Contact: YU Xianjun E-mail:

Abstract: Neuroendocrine neoplasms are rare and heterogenous, with low incidence, which can occur in multiple organs of the body. Gastroenteropancreatic neuroendocrine neoplasms have the highest incidence in China. 2017 version World Health Organization (WHO) classification of gastroenteropancreatic neuroendocrine neoplasms put forward the concept of well- differentiated neuroendocrine tumors (NET) G3. The related research has started to increase. This article reviewed the latest advances in clinical diagnosis and treatment of well-differentiated gastroenteropancreatic NET G3.

Key words: Neuroendocrine tumor, High-grade, Treatment progress, Prognosis